VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Pecora on Results from the Swedish PSA Study

Andrew L. Pecora, MD, FACP, CPE
Published: Wednesday, May 18, 2011

Andrew L. Pecora, MD, FACP, CPE the Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center on the results from the Swedish PSA Screening Study.

Dr. Pecora says the value of an elevated PSA is still trying to be determined in regards to offering men the proper option for care or, in some cases, no care and just routine follow-up. The large Swedish study has data that shows that based on a man's PSA at a younger age, it will be highly predictive of what their risk is later on in life of developing metastatic prostate cancer. The study shows that with proper testing early on, a man can avoid the need for many repeated testings and it appears can limit the testing under these circumstances to just three tests in a lifetime.
Andrew L. Pecora, MD, FACP, CPE the Chief Innovations Officer, Professor and Vice President of Cancer Services at John Theurer Cancer Center on the results from the Swedish PSA Screening Study.

Dr. Pecora says the value of an elevated PSA is still trying to be determined in regards to offering men the proper option for care or, in some cases, no care and just routine follow-up. The large Swedish study has data that shows that based on a man's PSA at a younger age, it will be highly predictive of what their risk is later on in life of developing metastatic prostate cancer. The study shows that with proper testing early on, a man can avoid the need for many repeated testings and it appears can limit the testing under these circumstances to just three tests in a lifetime.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x